Carbonic Anhydrase as Drug Target

Discover the intricate world of carbonic anhydrases with Carbonic Anhydrase as Drug Target by Daumantas Matulis. Published by Springer Nature Switzerland AG in 2019, this comprehensive hardback edition spans 353 pages of in-depth exploration into the thermodynamics and molecular structures of twelve catalytically active isoforms of human carbonic anhydrase (CA). This book emphasizes the critical role of inhibitor binding in drug design, making it an essential resource for researchers and professionals in biochemistry and pharmacology. Enhance your understanding of this vital enzyme and its potential as a drug target by diving into this expertly crafted work. Perfect for academics, students, and industry experts alike, Carbonic Anhydrase as Drug Target is a must-have addition to your scientific library.